Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Poster: Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution (Nitric Oxide-Donating Bimatoprost): A Double-Masked, Placebo-Controlled Phase 3b Clinical Trial

October 6, 2026

Previous